BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15361556)

  • 1. 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
    Ahrar K; Newman RA; Pang J; Vijjeswarapu MK; Wallace MJ; Wright KC
    J Vasc Interv Radiol; 2004 Sep; 15(9):901-5. PubMed ID: 15361556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
    Barone M; Ettorre GC; Ladisa R; Schiavariello M; Santoro C; Francioso G; Vinciguerra V; Francavilla A
    Hepatogastroenterology; 2003; 50(49):183-7. PubMed ID: 12630019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
    Leelawat K; Laisupasin P; Kiatdilokrut A; Pongtongpool T; Narong S; Samkhumphim N; Ket-Horm S
    J Med Assoc Thai; 2008 Oct; 91(10):1539-43. PubMed ID: 18972897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
    Okamoto E; Kinne RK; Sökeland J
    J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions.
    Yamagata M; Kanematsu T; Matsumata T; Utsunomiya T; Ikeda Y; Sugimachi K
    Eur J Surg Oncol; 1992 Aug; 18(4):379-82. PubMed ID: 1325926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
    Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
    Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
    J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma.
    Boulin M; Guiu S; Chauffert B; Aho S; Cercueil JP; Ghiringhelli F; Krause D; Fagnoni P; Hillon P; Bedenne L; Guiu B
    Anticancer Drugs; 2011 Sep; 22(8):741-8. PubMed ID: 21487286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
    Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN
    Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro.
    Lundgren-Eriksson L; Hultborn R; Henriksson R
    Anticancer Res; 2001; 21(5):3275-80. PubMed ID: 11848483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
    Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
    Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.
    Mostafa EM; Ganguli S; Faintuch S; Mertyna P; Goldberg SN
    J Vasc Interv Radiol; 2008 Dec; 19(12):1740-8. PubMed ID: 18951042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
    Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
    Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs.
    Herman TS; Sweets CC; White DM; Gerner EW
    J Natl Cancer Inst; 1982 Mar; 68(3):487-91. PubMed ID: 6950177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.